U.S. Markets open in 15 mins

Johnson & Johnson sees strong results in consumer, pharmaceutical ops

Despite ongoing pressure from an opioid lawsuit and a DOJ investigation, Johnson & Johnson reported a beat on earnings and revenue for Q2. Yahoo Finance's Dan Roberts, Anjalee Khemlani, Melody Hahm, and Myles Udland discuss.